BioNTech SE (BNTX) Other Gross PP&E Adjustments (2018 - 2025)
BioNTech SE (BNTX) posted Other Gross PP&E Adjustments of -$244.7 million for Q4 2025, down 4.13% on a QoQ basis from -$235.0 million in Q3 2025, and up 7.71% year-over-year from -$227.2 million in Q4 2024.
BioNTech SE (BNTX) has 8 years of Other Gross PP&E Adjustments data on file, last reported at -$244.7 million in Q4 2025.
- In Q4 2025, Other Gross PP&E Adjustments rose 7.71% year-over-year to -$244.7 million; the TTM figure through Dec 2025 stood at -$244.7 million (up 7.71% YoY), while the FY2025 annual figure was -$237.5 million, up 10.42% from the prior year.
- Other Gross PP&E Adjustments retreated to -$244.7 million in Q4 2025, from -$235.0 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$142.8 million in Q1 2021 and bottomed at -$276.1 million in Q2 2024.
- A 5-year average of -$237.5 million and a median of -$239.8 million in 2025 frame the typical range for Other Gross PP&E Adjustments.
- Annual changes were most pronounced in 2021 — Other Gross PP&E Adjustments tumbled 91.8% — and 2023, when it grew 21.8%.
- Year by year, Other Gross PP&E Adjustments stood at -$226.4 million in 2021, then increased by 4.51% to -$216.2 million in 2022, then declined by 6.7% to -$230.7 million in 2023, then declined by 14.93% to -$265.1 million in 2024, then rose by 7.71% to -$244.7 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$244.7 million (Q4 2025), -$235.0 million (Q3 2025), and -$253.9 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -189.30 Mn |
| 10 | BioNTech SE | 27.66 Bn | 7.53 Bn | 668.28 Mn | -244.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -244.68 Mn |
| Dec 31, 2025 | -244.68 Mn |
| Sep 30, 2025 | -234.98 Mn |
| Sep 30, 2025 | -234.98 Mn |
| Jun 30, 2025 | -253.90 Mn |
| Jun 30, 2025 | -253.90 Mn |
| Mar 31, 2025 | -254.45 Mn |
| Mar 31, 2025 | -254.45 Mn |
| Dec 31, 2024 | -265.12 Mn |
| Dec 31, 2024 | -265.12 Mn |
| Sep 30, 2024 | -265.77 Mn |
| Sep 30, 2024 | -265.77 Mn |
| Jun 30, 2024 | -276.11 Mn |
| Jun 30, 2024 | -276.11 Mn |
| Mar 31, 2024 | -248.02 Mn |
| Mar 31, 2024 | -248.02 Mn |
| Dec 31, 2023 | -230.68 Mn |
| Dec 31, 2023 | -230.68 Mn |
| Sep 30, 2023 | -214.45 Mn |
| Sep 30, 2023 | -214.45 Mn |
| Jun 30, 2023 | -220.94 Mn |
| Jun 30, 2023 | -220.94 Mn |
| Mar 31, 2023 | -223.68 Mn |
| Mar 31, 2023 | -223.68 Mn |
| Dec 31, 2022 | -216.19 Mn |
| Dec 31, 2022 | -216.19 Mn |
| Sep 30, 2022 | -274.25 Mn |
| Sep 30, 2022 | -274.25 Mn |
| Jun 30, 2022 | -260.04 Mn |
| Jun 30, 2022 | -260.04 Mn |
| Mar 31, 2022 | -222.90 Mn |
| Mar 31, 2022 | -222.90 Mn |
| Dec 31, 2021 | -226.39 Mn |
| Dec 31, 2021 | -226.39 Mn |
| Mar 31, 2021 | -142.82 Mn |
| Mar 31, 2021 | -142.82 Mn |
| Dec 31, 2020 | -118.04 Mn |
| Dec 31, 2020 | -118.04 Mn |
| Dec 31, 2019 | -60.90 Mn |
| Dec 31, 2019 | -60.90 Mn |
| Dec 31, 2018 | -56.80 Mn |
| Dec 31, 2018 | -56.80 Mn |